Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abeck D, Ring J (1998) Etablierte medizinische Therapieansätze. In: Ring J (ed) Neurodermitis. Expertise zur gesundheitlichen Versorgung und Vorsorge bei Kindern mit atopischem Ekzem. Ecomed, Landsberg, pp 93–105
Abeck D, Werfel S, Brockow K, Ring J (1997) Die Behandlung des atopischen Ekzems im Kindesalter. Hautarzt 48:379–383
Altounyan REC (1967) Inhibition of experimental asthma by a new compound disodium cromoglycate — “Intal”. Acta Allerg (Kbh) 22:487–489
Anonymous (2000) Doxepin cream for eczema? Drug Ther Bull 38:31–32
Barnes PJ (1996) Molecular mechanism of steroid action in asthma. J Allergy Clin Immunol 97: 159–168
Barnes W, Piper P, Castello J (1987) The effect of an oral LT antagonist L-649923 on histamine and leukotriene D4-induced bronchoconstriction in normal man. J Allergy Clin Immunol 79:816–821
Bernhard JD (1994) Itch. McGraw-Hill, Philadelphia
Betts T, Markman D, Debenham S, Mortiboy D, McKevitt T (1984) Effects of two antihistamine drugs on actual driving performance. Br Med J 288:281–282
Bieber T, Ring J (1987) Terfenadin und Kraftfahrzeug-Führung: Eine Placebo-kontrollierte Doppelblind-Studie zum Einfluß verschiedener Anti-histaminika auf das Fahrverhalten. Med Klin 82:683–686
Bovet D, Staub AM (1937) Action protectrice des ethers-phénoliques au cours de l’intoxication histaminique. CR Soc Biol (Paris) 124:547–549
Darsow U, Scharein E, Simon D, Walter G, Bromm B, Ring J (2001) New aspects of itch pathophysiology: component analysis of atopic itch using the ‘Eppendorf Itch Questionnaire’. Int Arch Allergy Immunol 124:326–331
Darsow U, Mautner V, Scharein E, Bromm B, Ring J (1997) Der Eppendorfer Juckreizfragebogen. Hautarzt 48:730–733
Dorsch W, Ring J (1984) Suppression of immediate and late anti-IgE-induced skin reactions by topically applied alcohol/onion extract. Allergy 39:43–49
Dorsch W, Auch E, Powerlowicz P (1987) Adverse effects of acetyl cysteine on human and guinea pig bronchial asthma in vivo and on human fibro-blasts and leukocytes in vitro. Int Arch Allergy Appl Immunol 82:33–39
Drake MD, Millikan LE (1995) The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Arch Dermatol 131:1403–1408
Forth H, Henschler D, Rummel W (1987) Allgemeine und spezielle Pharmakologie und Toxikologie, 5th edn. Wissenschaftsverlag, Mannheim
Foulds IS, McKie RM (1981) A double-blind trial of the H2-receptor antagonist cimetidine and the H1-receptor antagonist promethazine hydrochlo-ride in the treatment of atopic dermatitis. Clin Allergy 11:319
Hanifin JM (1991) Atopic dermatitis: New therapeutic considerations. J Am Acad Dermatol 24:1097–1101
Fjellner B, Hägermark Ö (1979) Pruritus in poly-cythemia vera: treatment with aspirin and possibility of platelet involvement. Acta Derm Venereol 59:505–512
Hansel TT, Barnes PJ (eds) (2001) New drug for asthma, allergy and COPI. Progr Resp Res 31. Karger, Basel
Hatz HJ (1998) Glucocorticoide. Immunologische Grundlagen, Pharmakologie und Therapierichtlinien. Wiss. Verlagsges., Stuttgart
Hirata F, Schiffmann E, Venkatasubramanian K, Salomon D, Axelrod J (1980) A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc Natl Acad Sci U S A 77:2533–2536
Hoffman C, Schatz M, Harden K, Forsythe A, Chillingar L, Porreco R, Benenson A, Sperling W, Kagnoff M, Saunders B, Zeiger R (1986) The safety of inhaled bronchodilators (IB) during pregnancy. J Allergy Clin Immunol 77:249
Kaiser H (1977) Cortisonderivate in Klinik und Praxis. Thieme, Stuttgart
Klein PA, Clark RAF (1999) An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol 135:1522–15625
Künig W, Baron M, Ehring F (1984) Effect of calcium mineral solutions on the histamine release from human peripheral leukocytes. Arzneimit-telforschung 34:52–54
Kunkel G, Schupp J, Borner K, Lasius D, Meysel U (1983) Untersuchungen zur Theophyllinwirkung unter besonderer Berücksichtigung der Tagesrhythmik. Therapiewoche 33:1113–1123
Manning PJ, Watson RM, Margolskee DJ, Williams VC, Schwartz JI, O’Byrne PM (1990) Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4 antagonist. N Engl J Med 323:1736–1739
Martin U, Römer D (1977) Ketotifen: A histamine release inhibitor. Monogr Allergy 12:145–149
Mazurek N, Berger G, Pecht I (1980) Binding site on mast cells and basophils for the antiallergic drug cromolyn. Nature 286:722–724
Melin L, Frederikson T, Noren P, Swebilius BG (1986) Behavioural treatment of scratching in patients with atopic dermatitis. Br J Dermatol 115: 467–474
Middleton ER Jr (1985) New drugs in management: calcium antagonists. Chest 87:79
Newton R (2001) Molecular mechanisms of glucocorticoid action. What is important? Thorax 55:603–613
Nolte D, Krejci G (1983) Methylxanthine beich. Apotheker-Verlag, Stuttgart
Ring J, Brockow K, Abeck D (1996) The therapeutic concept of “patient management” in atopic eczema. Allergy 51:206–215
Ring J, Fröhlich HH (1985) Wirkstoffe in der dermatologischen Therapie, 2nd edn. Springer, Berlin Heidelberg New York
Schmutzler W (1981) Möglichkeiten der Arzneitherapie allergischer Erkrankungen. Pharmakotherapie 4:155–162
Schmutzler W, Delmich K, Eichelberg D, Glück S, Greven T, Jürgensen H, Riesener KP, Risse G, Pult P (1985) The human adenoidal mast cell susceptibility to different secretagogues and secretion inhibitors. Int Arch Allergy Appl Immunol 77: 177–178
Simons KI, Simons FER (1996) H1-receptor antagonists: Pharmacokinetics and clinical pharmacology. In: Simons FER (ed) Histamine and H1-receptor antagonists in allergic disease. Dek-ker, New York, 175–213
Wassilew SW (2000) Serotoninantagonisten bei Pruritis. In: Plewig G, Degitz K (eds) Fortschritte der praktischen Dermatologie und Venerologie. Springer, Berlin Heidelberg New York, pp 437–440
Weinberger MM, Bronsky EA (1974) Evaluation of oral bronchodilator therapy in asthmatic children. J Pediatr 84:421
Woodward JK, Munro NL (1982) Terfenadine, the first non-sedating antihistamine. Arzneimittel-forschung/Drug Res 32:1154–1159
References
Aas K (1975) Clinical and experimental aspects of purification and standardization of allergen extracts. Int Arch Allergy Appl Immunol 49:44
Abramsom MJ, Puy RM, Weiner JM (1995) Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med 151:969–974
Akdis CA, Blaser K (2000) Mechanisms of allergen-specific immunotherapy. Allergy 55:522–530
André C, Vatrinet C, Galvain S, Carat F, Sicard H (2000) Safety of sublingual-swallow immunotherapy in children and adults. Int Arch Allergy Immunol 121:229–234
Asero R (2000) Fennel, cucumber, and melon allergy successfully treated with pollen-specific injection immunotherapy. Ann Allergy Asthma Immunol 84:460–462
Bauer CP, Czettritz G v, Weinmann HM (1984) Zerebrales Anfallsleiden — eine Kontra-Indikation für die Hyposensibilisierung? Allergologie 7: 161–162
Baumgarten C (1978) Häufigste Nebenwirkungen bei der spezifischen Hyposensibilisierung. Allergologie I:223–228
Berbis Ph, Carena MC, Auffranc JC, Privat Y (1986) Vascularite necrotisante cutaneo-systemique survenue en cours de desensibilisation. Ann Derm Venereol 113:805–809
Blaser K (2001) Immunologische Grundlagen der spezifischen Hyposensibilisierung. In: Ring J, Darsow U (eds) Allergie 2000. Dustri, Munich, pp 269–274
Bousquet J, Scheinmann P, Guinnepain MT, Perrin-Fayolle M, Sauvaget J, Tonnel AB, Pauli G, Caillaud D, Dubost R, Leynadier F, Vervloet D, Herman D, Galvain S, André C (1999) Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. Allergy 54:249–260
Braun W (1980) Hyposensibilisierung: Bericht über einen Todesfall in der Praxis. Therapiewoche 30:2215–2216
Brede HD, Aas K (eds) (1979) Allergen-Extrakte. Fischer, Stuttgart
Büchner K, Siepe M ((1995) Nutzen der Hyposensibilisierung unter wirtschaftlichen Aspekten. Allergo J 4:156–163
Casimir G, Gossart B, Vis HL, Duchateau J (1985) Antibody against beta-lactoglobulin (IgG) and cow’s milk allergy, J Allergy Clin Immunol 75:207
Clavel R, Bousquet J, André C (1989) Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis. Allergy 53:493–498
Creticos PS, Naclerio RM, Adkinson NF, Norman PS (1990) Efficacy, safety and kinetics of oral ragweed immunotherapy in the treatment of allergic seasonal rhinitis (Abstract). J Allergy Clin Immunol 85:165
Debelic M (1978) Behandlungserfolge mit Halb-Depot-Extrakten. In: Gronemeyer W, Fuchs E (eds) Allergosen der Atemwege. Dustri, Munich, 78 ff
Drachenberg KJ, Wheeler AW, Stuebner P, Horak F (2001) A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections. Allergy 56: 498–505
Düngemann H (1978) Karenz-Expositionsprophylaxe. Atemwegs-u Lungenkr 4:7
Durham SR, Walker SM, Varga EM, et al. (1999) Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 341:468–475
Ebner C (1999) Immunological mechanisms operative in allergen-specific immunotherapy. Int Arch Allergy Immunol 119:1–5
Frankland AW (1980) Anaphylactic reaction to desensitization. Br Med J 281:1429
Freeman EJ (1914) Vaccination against hay fever. Lancet 1:1178
Fuchs AM, Strauss MB (1959) The clinical evaluation and preparation and standardization of a new water-insoluble whole ragweed pollen complex. J Allergy 30:66
Fuchs E (1972) Praktische Durchführung einer spezifischen Hyposensibilisierung. Med Klin 67: 988
Georgitis JW, Nickelsen JA, Wypych JI, Barde SH, Clayton WF, Reisman RE (1986) Local intranasal immunotherapy with high-dose polymerizid ragweed extract. Int Arch Allergy Appl Immunol 81:170–173
Grewe M (2000) Hyposensibilisierung bei atopischem Ekzem. Allergo J 9:351–53
Gronemeyer W, Fuchs E (eds) (1983) Karenz und Hyposensibilisierung bei Inhalations-und Insektengift-Allergie, 2nd edn. Dustri, Munich
Horak F, Stubner P, Berger UE, Marks B, Toth J, Jäger S (1998) Immunotherapy with sublingual birch pollen extract. A short-term double-blind placebo study. J Invest Allergol Clin Immunol 8:165–171
Hunt KJ, Valentine MD, Sobotka AK, Benton AW, Amodio FJ, Lichtenstein LM (1978) A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 299:157
Jacobsen L, Dreborg S, Moller C, Valovirta E, Wahn U, Niggemann B, Koller D, Urbanek R, Halken S, Host A, Lowenstein H (1996) Immunotherapy as a preventive allergy treatment (abstract). J Allergy Clin Immunol 97:232
Jarisch R, Götz Aberer W (1988) Side effects of specific immunotherapy, reduction by pretreatment with antihistamines. J Allergy Clin Immunol 83:262
Jarisch R, Wöhrl S, Focke M, Hemmer W (2001) Anaphylaktische Reaktion bei spezifischer Immuntherapie durch Diaminoxidasehemmung nach Azetylzystein-Therapie. Allergologie 24: 112–115
Johansson SGO, Miller ACML, Overell BG, Wheeler AW (1974) Grass pollen-tyrosine adsorbate. Clin Allergy 4:57
Jung CM, Funk A, Rakoski J, Ring J (1997) Immunohistochemical analysis of late local skin reactions during rush venom immunotherapy. Allergy 52:717–726
Kasai M, Kurasawa K, Nakajima H, Iwamoto I (2001) T cell vaccination eliminates antigen-specific T cells and prevents antigen-induced eosinophil recruitment into the tissue. Int Arch Allergy Immunol 125[Suppl 1]:59–66
Kleinhans D, Zöller I (2000) Therapiestudien zur sublingualen Immuntherapie mit Allergenen. Eine aktuelle Bestandsaufnahme. Allergologie 23:349–353
Krieg AM, Hartmann G, Yi AK (2000) Mechanism of action of CpG DNA (review). Curr Top Microbiol Immunol 247:1–21
Lessof M, Sobotka AK, Lichtenstein LM (1976) Protection against anaphylaxis in hymenoptera sensitive patients by passive immunization. J Allergy Clin Immunol 57:246
Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC (1987) Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol 79:660–677
Lockey RF, Bukantz SC (eds) (1999) Allergens and allergen immunotherapy, 2nd edn. Marcel Dekker, New York
Lowell F, Frankling W (1965) A double-blind study of the effectiveness and specificity of injection therapy in ragweed hay fever. N Engl J Med 273:675–679
Løwenstein H (1986) Standardization of allergen extracts. In: Ring J, Burg G (eds) New trends in allergy II. Springer, Berlin Heidelberg New York, pp 266 292
Märtens P, Lobermeyer K (2001) Krankheitskosten-Studie und Kosten-Nutzen-Analyse der spezifischen Immuntherapy bei Asthma. Allergo J 10:341–347
Malling H-J (2001) Allergen-specific immunotherapy in allergic rhinitis. Curr Opin Allergy Clin Immunol 1:43–46
Marsh DG, Lichtenstein LM, Campbell DH (1970) Studies on allergoids prepared from naturally occurring allergens. I. Assay of allergenicity and antigenicity of formalinized rye group component. Immunology 18:705–722
Metzger WJ, Turner E, Patterson R (1978) The safety of immunotherapy during pregnancy. J Allergy Clin Immunol 61:268–272
Mueller DL, Jenkins MK (199) Molecular mechanisms underlying functional T cell unresponsiveness. Curr Opinion Immunol 7:375–381
Nelson HS, Iklé D, Buchmeier A (1996) Studies of allergen extract stability: The effects of dilution and mixing. Mosby Year Book, St. Louis, p 382
Noon L (1911) Prophylactic inoculation against hay-fever. Lancet 1572
Norman PS (1980) An overview of immunotherapy. J Allergy Clin Immunol 65:87
Norman PS, et al. (1996) Treatment of cat allergy with T-cell reactive peptides. Am J Respir Crit Care Med 154:1623–1628
Oppenheimer J, Areson JG, Nelson HS (1994) Safety and efficacy of oral immunotherapy with standardized cat extract. J Allergy Clin Immunol 93:61–67
Passalacqua G, Albano M, Fragonese L, et al. (1998) Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 351:629–632
Phanuphak P, Kohler PF (1980) Onset of polyarteritis nodosa during allergic hyposensitization treatment. Am J Med 68:479–485
Przybilla B, Ring J, Galosi A, Geursen RG, Stickl HA (1986) Bee-venom immunoglobulin for prophylaxis of anaphylactic reactions during bee venom immunotherapy (rush hyposensitization). Immunol Allergy Practice 8:107–111
Przybilla B, Ring J, Grießhammer B, Braun-Falco O (1987) Schnellhyposensibilisierung mit Hyme-nopterengiften — Verträglichkeit und Therapieerfolg. Dtsch Med Wochenschr 112:416–424
Punnonen J (2000) Molecular breeding of allergy vaccines and antiallergic cytokines. Int Arch Allergy Immunol 121:173–182
Rakoski J, Wessner D (2001) A short assessment of sublingual immunotherapy. Int Arch Allergy Immunol 126:185–187
Ring J, Bode U, Kadach U, Stix E, Burg G (1983) Gammaglobuline und Allergie. Klinische Ergebnisse einer kontrollierten Studie mit Standard-Immunglobulin G und Plazebo bei Pollinosis. Münch Med Wochenschr 125:289–292
Ring J (1987) Spezifische Hyposensibilisierung. Wirkungsmechanismen, Erfolge und Probleme. Allergologie 10:392–403
Ring J (1982) Successful hyposensitization treatment in atopic dermatitis: results of a trial in monozygotic twins. Br J Dermatol 107:597–602
Ring J (1993) Spezifische Hyposensibilisierung bei atopischem Ekzem. Allergo J 2:1–2
Ring J, Przybilla B, Bongardts J (1988) Safety of hyposensitization. In: Proceedings of the annual meeting of the EAACI, Plama de Mallorca, 22–26 April 1987. Abello, Madrid, pp 131–138
Schadewaldt H (1979–1982) Geschichte der Allergie, vols 1–4. Dustri, München-Deisenhofen
Schramm G, Kahler H, Suck R, et al. (1999) ‘Allergen engineering’: Variants of the timothy grass pollen allergen Phl p 5b with reduced IgE-binding capacity but conserved T cell reactivity. Immunology 162:2406–2414
Sehon AH, Lee WY (1981) Suppression of IgE antibodies with tolerogenic derivates of allergens. In: Ring J, Burg G (eds) New trends in allergy. Springer, Berlin Heidelberg New York, p 294
Taylor G, Shivalkar PR (1972) Local nasal desensitization in allergic rhinitis. Clin Allergy 2:125
Turkeltaub PC, Marsh DG, Lichtenstein LM, Norman PS (1978) Development of long-lasting immediate hypersensitivity in nonatopic volunteers parenterally immunized with a purified grass pollen extract. J Allergy Clin Immunol 61:171
Ulrich JT, Myers KR (1995) Monophosphoryl lipid A as an adjuvant. Past experiences and new directions. In: Powell MF, Newman MJ (eds) Vaccine design: the subunit and adjuvant approach. Plenum Press, New York, pp 495–524
Umetsu DT, Hahn JS, Perez-Atayde AR, Geba RS (1985) Serum sickness triggered by anaphylaxis. A complication of immunotherapy. J Allergy Clin Immunol 76:713–718
Urbanek R, Karitzky D, Forster J (1978) Die Hyposensibilisierungsbehandlung mit reinem Bienengift. Dtsch Med Wochenschr 103:1656
Valenta R, Kraft D (1995) Recombinant allergens for diagnosis and therapy of allergic diseases. Curr Opin Immunol 7:751–756
Vervloet D, Khairallah E, Arnaud A, Charpin J (1980) A prospective national study of the safety of immunotherapy. Clin Allergy 10:59–64
Wahn U, Rebien W (1979) Ergebnisse der oralen Hyposensibilisierung bei kindlichen Pollenallergikern. Pädiat Prax 21:455
Wheeler AW, Woroniecki SR (2001) Immunological adjuvants in allergy vaccines: Past, present and future. Allergology Int 50:295–301
Wilson DR, Nouri-Aria KT, Walker SM, Pajno GB, O’Brien F, Jacobson MR, Mackay IS, Durham SR (2001) Grass pollen immunotherapy: Symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season. J Allergy Clin Immunol 107:971–976
Wortmann F (1976) Zur oralen Desensibilisierung von Inhalationsallergien bei Kindern. Mschr Kinderheilk 124:218
Wüthrich B ((1977) Zur spezifischen Hyposensibilisierung der Pollinosis. Schweiz Rundsch Med 66:260
Yang WH, Dorval G, Osterland CK, Gilmore NJ (1979) Circulating immune complexes during immunotherapy. J Allergy Clin Immunol 63: 305–307
Zachariae H, Cramers M, Herlin T, Jensen J, Kragbale K, Ternowitz T, Thestrup-Petersen K (1985) Non-specific immunotherapy and specific hyposensitization in severe atopic dermatitis. Acta Derm Venereol (Stockh) [Suppl] 114:48–54
Zimmermann S, Egeter O, Hausmann S, Lipford GB, Röcken M, Wagner H, Heeg K (1998) CpG oligodeoxynucleotides trigger, protective and curative Th1 responses in lethal murine leishmaniasis. J Immunol 160:3627–3630
Positions Papers
World Health Organization (WHO) Bousquet J, Lockey RF, Malling HJ, et al. (1998) WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 53[Suppl 44]:1–42
European Academy of Allergy and Clinical Immunology (EAACI) Bousquet J, Müller UR, Dreborg S, et al. (1987) Immunotherapy with Hymenoptera venoms. Allergy 42:40–413
Malling H-J, Abreu-Nogueira J, Alvarez-Cuesta E, et al. (1998) Local immunotherapy. Position paper by the Working Group on Local Immunotherapy of the EAACI Subcommittee and the ESPACI Immunotherapy Subcommittee. Allergy 53:933–944
Ärzteverband Deutscher Allergologen (ÄDA) Sennekamp J, Kersten W, Hornung B (1995) Empfehlungen zur Hyposensibilisierung mit Allergenextrakten. Allergo J 4:205–212
Deutsche Gesellschaft für Allergologie und klinische Immunologie (DGAI) Kleine-Tebbe J, Fuchs T, Klimek L, et al. (2000) Die spezifische Immuntherapie (Hyposensibilisierung) mit Allergenen. Positionspapier der DGAI, inhaltlich abgestimmt mit dem ÄDA. Allergo J 6 (in press)
References
Abraham RT (1998) Mammalian target of rapamycin: Immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling. Curr Opin Immunol 10:330–336
Brendel W, Ring J, Seifert J (1974) Experimental and clinical aspects of ALG. Progr Immunol II 5:245–252
Busse W, Corren J, Lanier BQu, McAlary M, Fowler-Taylor A, Della Cioppa G, van As A, Gupta N (2001) Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 108:184–190
Hansel TI, Barnes PJ (eds) (2001) New drugs for asthma, allergy and COPD. Karger, Basel
Heusser C, Jardieu P (1997) Therapeutic potential of anti-IgE antibodies. Curr Opin Immunol 9: 805–814
Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kaszica J, Schwieterman WD, Siegel JJN, Braun MM (2001) Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N Engl J Med 345:1098–1104
Jardieu PM, Fick RB Jr (1999) IgE inhibitors as a therapy for allergic disease. Int Arch Allergy Immunol 118:112–115
Krieg AM (1996) An innate immune defence mechanism based on the recognition of CpG motifs in microbial DANN. J Lab Clin Med 128: 128–133
Leckie MJ, ten Brinke A, Lordan J, Khan J, Diamant Z, Walls CM, Cowley D, Hansel T, Djukanovic R, Sterk PJ, Holgate S, Barnes PJ (1999) SB 240563, a humanised anti-IL-5 monoclonal antibody: initial single dose safety and activity in patients with asthma. Am J Resp Crit Care Med 159:A624
Losman JA, Chen XP, Hilton D, Rothman P (1999) SOCS-1 is a potent inhibitor of IL-4 signal transduction. J Immunol 162:3770–3774
Milgrom H, Fick RB, Su JQ, Reimann JD, Bush RK, Watrous ML (1999) Treatment of allergic asthma with monoclonal anti-IgE antibody. N Engl J Med 341:1966–1973
Prinz B, Nachbar T, Plewig G (1994) Treatment of severe atopic dermatitis with extracorporal photophoresis. Arch Dermatol Res 287:48–52
Reitamo S (2001) Tacrolimus: A new topical immunomodulatory therapy for atopic dermatitis. J Allergy Clin Immunol 107:445–448
Renz H, Bradley K, Enssel K, Loader JE, Larsen GL, Gelfand EW (1996) Prevention of the development of immediate hypersensitivity and airway hyperresponsiveness in vivo with soluble IL-4 receptors. Int Arch Allergy Immunol 106:167
Ring J, Seifert J, Lob G, Coulin K, Angstwurm H, Frick E, Brass B, Mertin J, Backmund H, Brendel W (1974) Intensive immunosuppression in the treatment of multiple sclerosis. Lancet 2:1093–1095
Sacher R, FRCPC, and the IVIG Advisory Panel (2001) Intravenous immunoglobulin consensus statement. J Allergy Clin Immunol 108:S139–146
Saint-Remy J-MR (1999) Allergisches Bronchialasthma: Immuntherapie durch Antikörper. Die gelben Hefte 39:59
Szczeklik A, Nizankowska E, Dworski R, Domagala B, Pinis G (1991) Cyclosporine for steroid dependent asthma. Allergy 46:312–315
Tony H-P, Shen B-J, Reusch P, Sebald W (1994) Design of human interleukin-4 antagonists to inhibiting interleukin-4-dependent and interleukin-13-dependent responses in T cells and B cells with high efficiency. Eur J Biochem 225:659–665
References
Bock KD (1993) Wissenschaftliche und alternative Medizin. Springer, Berlin Heidelberg New York
Davenas E, Beauvais F, Amara J, et al. (1988) Human basophil degranulation triggered by very dilute antiserum against IgE. Nature 333:816–818
De Weck AL (2000) From basic science to complementary medicine. ACI Int 13:5–6
Dorsch W, Ring J (2002) Komplementärmethoden bzw. sog. “Alternativmethoden” in der Aller-gologie. Allergo J 11:163–170
Dorsch W (1996) Alternative Heilmethoden in der Allergologie? Allergo J 5:388–393
Fulder SJ, Munro RE (1985) Complementary medicine in the United Kingdom: Patients, practitioners, and consultations. Lancet II:542–545
Fung KP, Chow O, So SY (1986) Attenuation of exercise-induced asthma by acupuncture. Lancet II:1419–1422
Köbberling J (1997) Der Wissenschaft verpflichtet. Med Klin 92:171–190
Kofler H, Ulmer H, Mechter E, Falk M, Fritsch PO (1996) Bioresonanz bei Pollinose: Eine vergleichende Untersuchung zur diagnostischen und therapeutischen Wertigkeit. Allergologie 19:114–122
Kukutsch NA (1997) Darstellung und Diskussion alternativer/komplementärer diagnostischer und/oder therapeutischer Konzepte im Hinblick auf atopische Erkrankungen. Dissertation, Hamburg
Lambeck M (2001) Eine Revolution der Physik? Die Unterstützung der Homöpathie und ähnlicher Therapieeinrichtungen durch die Krankenkassen. Skeptiker 14:117–122
Lüdtke R, Kunz B, Seeber N, Ring J ((2001) Test-retest reliability and validity of the kinesiology muscle test. Complement Ther Med 9:141–145
Oepen I, Prokop O (1985) Außenseitermethoden in der Medizin. Wissenschaftl. Buchgesellschaft, Darmstadt
Miller MJS, Vergnolle N, McKnight W, et al. (2001) Inhibition of neurogenic inflammation by the Amazonian herbal medicine Sangre del Grado. J Invest Dermatol 117:725–730
Ring J, Behrendt H, Vieluf D (eds) (1997) New trends in allergy IV. Springer, Berlin Heidelberg New York
Ring J (ed) (1998) Neurodermitis. Expertise zur gesundheitlichen Versorgung und Vorsorge bei Kindern mit atopischem Ekzem. Ecomed, Landsberg
Schäfer T, Riehle A, Wichmann HE, Ring J (2002) Alternative medicine in allergies — prevalence, patterns of use, and costs. Allergy 57:684–700
Schöni MH, Nikolaizik WH, Schöni-Afolter F (1997) Efficacy trial of bioresonance in children with atopic dermatitis. Int Arch Allergy Immunol 112:238–246
Sheehan MP, Atherton DJ (1992) A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema. Br J Dermatol 126:179–184
Siebenwirth J, Rakoski J (1997) Klassisch-homö-opathische Therapie bei Neurodermitis. Hautarzt 48[Suppl 1]:S22
Stiftung Warentest (ed) (1996) Handbuch Die andere Medizin. Nutzen und Risiken sanfter Heilmethoden, 4th edn. Stiftung Warentest, Berlin
Wiesenauer M, Gaus W, Häussler S (1990) Behandlung der Pollinosis mit Galphimia glauca. Allergologie 13:359–363
Wong HCG (2001) Chinese herbal medicine and allergy. ACI Int 13:192–196
Wüthrich B (1999) Allergologie: Quo vadis? Schweiz Med Wochenschr 129:905–914
References
Arlian LG, Platts-Mills TAE (2001) The biology of dust mites and the remediation of mite allergens in allergic disease. J Allergy Clin Immunol 107:S406–413
Behrendt H, et al. (1999) Der Rat von Sachverständigen für Umweltfragen. Umwelt und Gesundheit. Risiken richtig einschätzen. Sondergutachten. Metzler-Poeschel, Stuttgart
Bergmann K-Ch (2001) Allergenkarenz bei allergischem Asthma. In: Ring J, Darsow U (eds) Allergie 2000. Dustri, Munich, pp 164–168
Bischoff E, Krause-Michel B, Nolte D (1986) Zur Bekämpfung der Hausstaubmilben in Haushalten von Patienten mit Milbenasthma. Allergologie 9:448–457
Björkstén B, Sepp E, Julge K, Voor T, Mikelsaar M (2001) Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 108:516–520
Boehm G, Leuschner RM (eds) (1987) Advances in aerobiology. Experientia [Suppl] 51:197–202
Borelli S (1997) Deutsche Klinik für Dermatologie und Allergie Davos (Alexanderhausklinik) 1960–1995. Stiftung Derm All Forschung, Davos
Bucher H, Gutzwiller F (eds) (1993) Checkliste Gesundheitsberatung und Prävention. Thieme, Stuttgart
Cloosterman SGM, Schermer TRJ, Bijl-Hofland ID, et al. (1999) Effects of house dust mite avoidance measures on Der p1 concentrations and clinical condition of mild adult house dust mite-allergic asthmatic patients, using no inhaled steroids. Clin Exp Allergy 29:1336–1346
Colloff MJ, Ayres J, Carswell F, Howarth PH, Merret TG, Mitchell EB, Walshaw MJ, Warner JO, Warner JA, Woodcock AA (1992) The control of allergens of dust mite and domestic pets: a position paper. Clin Exp Allergy 22[Suppl 2]:1–28
Colloff MJ, Taylor C, Merrett TG (1995) The use of domestic steam cleaning for the control of house dust mites. Clin Exp Allergy 25:1061–1066
DGAI-Stellungnahme: Ring J et al. (1993) Allergie-Prävention. Allego J 2:36–37
Diebschlag W, Diebschlag B (2000) Hausstauballergien. Gesundheitliche und hygienische Aspekte, 2nd edn. Herbert Utz Verlag, Munich
Disch R, Schöne D (1995) Prävention in der Dermatologie. Präv Rehabil 3:155–160
Eggleston PA, Bush RK (2001) Environmental allergen avoidance: An overview. J Allergy Clin Immunol 107:S403–405
Ehnert B, Lau-Schadendorf S, Weber A, et al. (1992) Reducing domestic exposure to dust mite allergen reduces bronchial hyperreactivity in sensitive children with asthma. J Allergy Clin Immunol 90:135–138
Ewers U, Kainka E, Umbach KH, Diebschlag W (2000) Methoden zur Überprüfung der Qualitätsanforderungen an milbenallergendichte Matratzen-und Bettbezüge (Encasings). Allergo J 9:261–26
ETAC Study Group (1998) Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised placebo-controlled trial: first results of ETAC. Pediatr Allergy Immunol 9:116–124
Fröschl M (2000) Gesund sein. Integrative Gesund-Seins-Förderung als Ansatz für Pflege, soziale Arbeit und Medizin. Lucius u. Lucius, Stuttgart
Gieler U, Niemeier V, Kupfer J, Brosig B (2001) Psychosomatische Konzepte in der Allergologie. In: Ring J, Darsov U (eds) Allergie 2000. Dustri, Munich, pp 189–192
Götzsche PC, Hammarquist C, Burr M (1998) House dust mite control measures in the management of asthma: meta-analysis. BMJ 317:1105–1110
Grootendorst DC, Dahlén S-E, van den Bos JW, Duiverman EJ, Veselic-Charvat M, Vrijlandt EJLE, O’sullivan S, Kumlin M, Sterk PJ, Roldaan AC (2001) Benefits of high altitude allergen avoidance in atopic adolescents with moderate to severe asthma, over and above treatment with high dose inhaled steroids. Clin Exp Allergy 31:400–408
Huss K, Squire EN Jr, Carpenter GB, Smith LJ, Huss RJ, Salata K, Salerno M, Agostinelli D, Hershey J (1992) Effective education of adults with asthma who are allergic to dust mites. J Allergy Clin Immunol 89:836–843
Isolauri E, Arvola T, Sütas Y, Moilanen E, Salminen S ((2000) Probiotics in the management of atopic eczema. Clin Exp Allergy 30:1604–1610
Johansson SGO, Haahtela T (eds) (2000) Prevention of allergy and asthma. Interim report. Based on the WHO/IAACI Meeting on the Primary Prevention of Allergy and Asthma. Allergy 55:1069–1088
Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E (2001) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357:1076–1079
Kjellman N-I M, Nilsson L (1999) Is allergy prevention realistic and beneficial? Pediatr Allergy Immunol 10[Suppl 12]:11–17
Kniest FM, Liebenberg B, Ahr A (1992) Mattress-encasings as a barrier for mites and airborne dust. J Aerosol Sci 23[Suppl I]:S551–554
Korsgaard J (1982) Preventive measures in housedust allergy. Am Rev Respir Dis 125:80–84
Kroidl RF (1992) Allergie gegen Hausstaubmilben: Sanierungsmaßnahmen: Konventionell? Mit akariziden Mitteln? Allergologie 15:197–201
Lau S, Falkenhorst G, Weber A, Werthman I, Lind P, Buettner-Goetz P, Wahn U (1989) High mite-allergen exposure increases the risk of senzitization in atopic children and young adults. J Allergy Clin Immunol 84:718–725
Liccardi G, Custovic A, Cazzola M, Russo M, D’Amato M, D’Amato G (2000) Avoidance of allergens and air pollutants in respiratory allergy. Allergy 56:705–722
Medici TC, Radielovic P, Morley J (1989) Ketotifen in the prophylaxis of extrinsic bronchial asthma. A multicenter controlled double-blind study with a modified-release formulation. Chest 96:1252–1257
Müsken H, Wahl R, Franz J-Th, Masuch G, Sauter Ch, Bergmann K-Ch ((1996) Häufigkeit von Hausstaubmilben-Sensibilisierung. Allergologie 19:29–34
Nishioka K, Yasueda H, Saito H (1998) Preventive effect of bedding encasement with microfine fibers on mite sensitization. J Allergy Clin Immunol 101:28–32
Peat JK, Britton WJ, Salome CM, Woolcock AJ (1987) Bronchial hyperresponsiveness in two populations of Australian school children. III. Effect of exposure to environmental allergens. Clin Allergy 17:291–330
Platts-Mills TAE, Rovvey ER, Mitchell EB, Moszoro H, Nock P, Wilkins SR (1982) Reduction of bronchial hyperreactivity during prolonged allergen avoidance. Lancet III:675–678
Platts-Mills T, Vaughan J, Squillace S, Woodfolk J, Sporik R (2001) Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet 357:752–756
Pürschel W ((1973) Dermatologische Klimatherapie an der Nordsee. Dermatologica 146[Suppl 1]:1–98
Ring J, Abeck D (1996) Vom “Patienten-Management” zum “Selbst-Management”: Prävention durch Schulung bei atopischem Ekzem (Neurodermitis). In: Stützner W, Giesler M (eds) Prävention allergischer Erkrankungen im Kindes-und Jugendalter. Kohlhammer, Stuttgart, pp 32–41
Ring J, Gfesser M (1997) Atopieprävention. In: Plewig G, Przybilla B (eds) Fortschritte der praktischen Dermatologie und Venerologie, vol 15. Springer, Berlin Heidelberg New York, pp 317–321
Ring J, Wenning J (eds) (2000) Weißbuch: Allergie in Deutschland 2000. Urban und Vogel, Munich
Ring J, Schäfer T (2001) Vernetzungsansätze in der Allergieforschung. In: Aktionsbündnis Allergieprävention. BMG, Bonn, pp 21–25
Saarinen U, Kajosaari M (1995) Breastfeeding as prophylaxis against atopic disease: prospective follow-up study until 17 years old. Lancet 346:1065–69
Schober G (1988) Feuchte und Entwicklung von Wohnungsallergenen. Allergologie 11:229–234
Schoenecker I, Grübl A, Bartels P, Ulm K, Bauer CP (2001) Klinische Effekte der Allergenreduktion durch Encasing — eine Metaanalyse. Allergy J 10:95–99
Schultze-Werninghaus (1993) Allergenkarenz bei inhalativer Allergie. In: Manuale allergologicum, VII.1, Dustri, Munich, pp 1–9
Stiftung Deutscher Polleninformationsdienst (1997) 1. Europäisches Pollenflug-Symposium. Verlag für Medizin und Umwelt, Krefeld
Stünzner W, Giesler M (eds) (1996) Prävention allergischer Erkrankungen im Kindes-und Jugendalter. XXIII. Kongreß der Deutschen Zentrale für Volksgesundheitspflege e.V. (DZV). Kohlhammer, Stuttgart
Tan BB, Weald D, Strickland I, et al. (1996) Double-blind controlled trial of effect of housedustmite allergen avoidance on atopic dermatitis. Lancet 347:15–18
van Leeuwen S (1926) Allergische Krankheiten. Asthma bronchiale, Heufieber, Urticaria und andere. Dtsch Übers von Verzár F. Springer, Berlin Heidelberg New York
Vandenhove T, Soler M, Birnbaum J, Charpin D, Vervloet D (1993) Effect of dry cleaning on mite allergen levels in blankets. Allergy 48:264–266
Vervloet D, Penaud A, Razzouk H, Senft M, Arnaud A, Boutin C, Charpin J (1982) Altitude and house dust mites. J Allergy Clin Immunol 69:290–296
Vocks E, Borelli S, Rakoski J (1994) Klimatherapie bei Neurodermitis. Allergologie 17:208–213
Wahn U (1987) Möglichkeiten der Allergieprophylaxe bei Säuglingen und Kleinkindern. Allergologie 10:362–364
Wahn U, von Mutius E (2001) Childhood risk factors for atopy and the importance of early intervention. J Allergy Clin Immunol 107:567–574
Wanner H-U (1994) Biologische Verunreinigungen in der Raumluft. Allergologie 17:526–529
Wood RA, Chapman MD, Adkinson NF Jr, Eggleston PA (1989) The effect of cat removal on allergen content household dust samples. J Allergy Clin Immunol 83:730–734
Zock JP, Brunekreef B (1995) House dust mite allergen levels in dust from schools with smooth and carpeted classroom floors. Clin Exp Allergy 25:549–553
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2005). Allergy Prevention and Therapy. In: Allergy in Practice. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26584-8_6
Download citation
DOI: https://doi.org/10.1007/3-540-26584-8_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-00219-2
Online ISBN: 978-3-540-26584-9
eBook Packages: MedicineMedicine (R0)